Insulin degludec and liraglutide Subcutaneous and Ramucirumab Intravenous
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Ranexa
- Insulin degludec and liraglutide Subcutaneous-Ranibizumab
- Insulin degludec and liraglutide Subcutaneous-Ranibizumab Intraocular
- Insulin degludec and liraglutide Subcutaneous-Ranibizumab ophthalmic
- Insulin degludec and liraglutide Subcutaneous-Ranitidine
- Insulin degludec and liraglutide Subcutaneous-Ranitidine Capsule
- Ramucirumab Intravenous-Insulin degludec Subcutaneous
- Ramucirumab Intravenous-Insulin detemir
- Ramucirumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ramucirumab Intravenous-Insulin Detemir (Vials)
- Ramucirumab Intravenous-Insulin detemir Subcutaneous
- Ramucirumab Intravenous-Insulin glargine